229 related articles for article (PubMed ID: 33401933)
1. MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
Oeing CU; Jun S; Mishra S; Dunkerly-Eyring BL; Chen A; Grajeda MI; Tahir UA; Gerszten RE; Paolocci N; Ranek MJ; Kass DA
Circ Res; 2021 Mar; 128(5):639-651. PubMed ID: 33401933
[TBL] [Abstract][Full Text] [Related]
2. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
[TBL] [Abstract][Full Text] [Related]
3. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.
Oeing CU; Nakamura T; Pan S; Mishra S; Dunkerly-Eyring BL; Kokkonen-Simon KM; Lin BL; Chen A; Zhu G; Bedja D; Lee DI; Kass DA; Ranek MJ
Circ Res; 2020 Jul; 127(4):522-533. PubMed ID: 32393148
[TBL] [Abstract][Full Text] [Related]
4. Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy.
Davogustto GE; Salazar RL; Vasquez HG; Karlstaedt A; Dillon WP; Guthrie PH; Martin JR; Vitrac H; De La Guardia G; Vela D; Ribas-Latre A; Baumgartner C; Eckel-Mahan K; Taegtmeyer H
J Mol Cell Cardiol; 2021 Sep; 158():115-127. PubMed ID: 34081952
[TBL] [Abstract][Full Text] [Related]
5. TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy.
Patel CH; Dong Y; Koleini N; Wang X; Dunkerly-Eyring BL; Wen J; Ranek MJ; Bartle LM; Henderson DB; Sagert J; Kass DA; Powell JD
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37788104
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.
Wang J; Filippakis H; Hougard T; Du H; Ye C; Liu HJ; Zhang L; Hindi K; Bagwe S; Nijmeh J; Asara JM; Shi W; El-Chemaly S; Henske EP; Lam HC
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34544857
[TBL] [Abstract][Full Text] [Related]
7. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.
Zhan J; Chitta RK; Harwood FC; Grosveld GC
Mol Cell Biochem; 2019 Jun; 456(1-2):123-134. PubMed ID: 30684133
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
11. Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt.
Dunkerly-Eyring BL; Pan S; Pinilla-Vera M; McKoy D; Mishra S; Grajeda Martinez MI; Oeing CU; Ranek MJ; Kass DA
Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35288456
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection via preserved mitochondrial structure and function in the mPer2-mutant mouse myocardium.
Virag JA; Anderson EJ; Kent SD; Blanton HD; Johnson TL; Moukdar F; DeAntonio JH; Thayne K; Ding JM; Lust RM
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H477-83. PubMed ID: 23771689
[TBL] [Abstract][Full Text] [Related]
13. Methionine controls insulin/mammalian target of rapamycin complex 1 activity by modulating tuberous sclerosis complex 2 stability.
Gen S; Matsumoto Y; Suzuki T; Inoue J; Yamamoto Y
Biochem Biophys Res Commun; 2021 Feb; 541():84-89. PubMed ID: 33482580
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
[TBL] [Abstract][Full Text] [Related]
15. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
16. TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.
Ogórek B; Lam HC; Khabibullin D; Liu HJ; Nijmeh J; Triboulet R; Kwiatkowski DJ; Gregory RI; Henske EP
Hum Mol Genet; 2018 May; 27(9):1654-1663. PubMed ID: 29509898
[TBL] [Abstract][Full Text] [Related]
17. HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer.
Liu B; Zhang J; Meng X; Xie SM; Liu F; Chen H; Yao D; Li M; Guo M; Shen H; Zhang X; Xing L
Oncogene; 2023 Apr; 42(15):1181-1195. PubMed ID: 36823378
[TBL] [Abstract][Full Text] [Related]
18. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning.
Yang FH; Pyle WG
J Mol Cell Cardiol; 2012 Mar; 52(3):761-72. PubMed ID: 22155006
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.
Nadtochiy SM; Urciuoli W; Zhang J; Schafer X; Munger J; Brookes PS
J Mol Cell Cardiol; 2015 Nov; 88():64-72. PubMed ID: 26388263
[TBL] [Abstract][Full Text] [Related]
20. A new homozygous HERC1 gain-of-function variant in MDFPMR syndrome leads to mTORC1 hyperactivation and reduced autophagy during cell catabolism.
Schwarz JM; Pedrazza L; Stenzel W; Rosa JL; Schuelke M; Straussberg R
Mol Genet Metab; 2020; 131(1-2):126-134. PubMed ID: 32921582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
